Adipotrim XT — Class I drug recall D-1277-2014
Terminated recall by Deseo Rebajar, reported 2014-05-07, distributed nationwide. Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplem
| Recall number | D-1277-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Deseo Rebajar, Fajardo, PR, United States |
| Recall initiated | 2013-11-07 |
| Classified | 2014-04-25 |
| Reported by FDA | 2014-05-07 |
| Terminated | 2017-05-03 |
| Distributed | Nationwide (US) |
| Quantity | 1,146 bottles |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 052012 |
| Expiration dates | 2015-10 |
Product
Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com.
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1277-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.